// App-Quantinova.ai

e20083 : Pegylated arginase treatment in mesothelioma xenograft models.

Researchers

Presenter

  • James C. M. Ho

Principal Investigators

  • Sze Kwan Lam

  • kin Pong U

  • Paul Ning-Man Cheng

Medical Centers

  • University of Hong Kong, Hong Kong, China

  • The Chinese University of Hong Kong, Hong Kong, Hong Kong

  • Bio-Cancer Treatment International Limited, Hong Kong, Hong Kong

  • 813 Medical Centre Ltd, Central, Hong Kong

Locations

  • China

  • Hong Kong

Companies

  • Bio-Cancer Treatment

  • 813 Medical Centre L

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Mesothelioma

Biomarkers

  • Nucleoside diphosphate kinase A

Drug/Treatment

  • Arginine hydrochloride

  • PEGylated recombinant human arginase 1

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved